Ranitidin-ratiopharm en es it fr

Ranitidin-ratiopharm Brand names, Ranitidin-ratiopharm Analogs

Ranitidin-ratiopharm Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitidin-ratiopharm Chemical_Formula


Ranitidin-ratiopharm RX_link


Ranitidin-ratiopharm fda sheet

Ranitidin-ratiopharm FDA

Ranitidin-ratiopharm msds (material safety sheet)

Ranitidin-ratiopharm MSDS

Ranitidin-ratiopharm Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidin-ratiopharm Molecular Weight

314.405 g/mol

Ranitidin-ratiopharm Melting Point

69-70 oC

Ranitidin-ratiopharm H2O Solubility

24.7 mg/mL

Ranitidin-ratiopharm State


Ranitidin-ratiopharm LogP


Ranitidin-ratiopharm Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidin-ratiopharm Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidin-ratiopharm Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidin-ratiopharm Absorption

Approximately 50% bioavailability orally.

Ranitidin-ratiopharm side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidin-ratiopharm Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidin-ratiopharm Organisms Affected

Humans and other mammals